| Trade Names: | |
| Synonyms: | |
| Status: | Approved (2002) |
| Entry Type: | Small molecule |
| Molecule Category: | Salt |
| UNII: | 3X6SAX83JZ |
| Parent Compound: | ZIPRASIDONE |
| InChI Key | LOQSYPGSAZUDJZ-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C22H31ClN4O7S2 |
| Molecular Weight | 563.1 |
| AlogP | 3.81 |
| Hydrogen Bond Acceptor | 5.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 4.0 |
| Polar Surface Area | 48.47 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 3.0 |
| Heavy Atoms | 28.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| ANTAGONIST | Dopamine D2 receptor antagonist | DailyMed |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Schizophrenia | 3 | D012559 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEBI | 53757 |
| ChEMBL | CHEMBL3989833 |
| FDA SRS | 3X6SAX83JZ |
| PubChem | 656685 |
| SureChEMBL | SCHEMBL957178 |